These medtech companies raised the most VC last year


3. Respicardia

Minnetonka, Minn.
Venture capital raised: $58.5 million


Respicardia raised $58.5 million in venture capital in its early and later stages of development during the fourth quarter of 2017, according to the MoneyTree Report. This is the company’s eighth investment sequence. One of the investors is ZOLL Medical.

Respicardia is creating implantable therapies that can improve respiratory and cardiovascular health. The company’s Remede System is an implantable stimulation device that restores a regular breathing pattern during sleep for central sleep apnea patients.

Next >>

Join the Best Minds in MedTech at DeviceTalks Minnesota!

textadimage This year’s DeviceTalks Minnesota features four tracks packed with expertly curated content created by the industry for the industry.

ECO-SYSTEM TRACK: focuses on issues impacting medtech companies across Minnesota and beyond. TECHNOLOGY TRACK: drills down on the hottest new tech that is changing medtech. REGULATORY 201 and CLINCAL 201 TRACKS: Hosted by Medical Alley and focuses on the most important trends in regulatory and clinical development.

Take a look at our full agenda.

Use the code "TRACKS" to save 15% on the cost of registration. 


Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Speak Your Mind